Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity

@article{Montaudi2011MethotrexateIP,
  title={Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity},
  author={H. Montaudi{\'e} and E. Sbidian and C. Paul and A. Maza and A. Gallini and S. Aractingi and F. Aubin and H. Bachelez and B. Cribier and P. Joly and D. Jullien and M. Le Ma{\^i}tre and L. Misery and M. Richard and J. Ortonne},
  journal={Journal of the European Academy of Dermatology and Venereology},
  year={2011},
  volume={25}
}
  • H. Montaudié, E. Sbidian, +12 authors J. Ortonne
  • Published 2011
  • Medicine
  • Journal of the European Academy of Dermatology and Venereology
  • Background/Aim  To define practical use and to specify the ideal method for monitoring the liver toxicity of MTX in the management of psoriasis. 
    136 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    This study is a prospective, single blinded, randomized, pilot study to compare the effectiveness and safety profile of oral versus subcutaneous route of administration of… Expand
    ConditionsPsoriasis Vulgaris
    InterventionDrug
    Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists
    • 20
    • PDF
    Evidence‐based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists
    • 63
    A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis
    • 98
    Systemic methotrexate for the treatment of psoriasis
    • 24
    The possibilities and principles of methotrexate treatment of psoriasis – the updated knowledge
    • 38
    • PDF

    References

    SHOWING 1-10 OF 34 REFERENCES
    Evidence‐based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists
    • 63
    Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis
    • 37
    Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
    • 264
    • PDF